The public health imperative for a neonatal herpes simplex virus infection surveillance system

Sexually Transmitted Diseases

Volumn 33, Issue 3, 2006, Pages 170-174

  Donoval, Betty A ^a   Passaro, Douglas J ^a   Klausner, Jeffrey D ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; HERPES SIMPLEX VACCINE;

ARTICLE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; GENITAL HERPES; HEALTH PROGRAM; HEALTH SURVEY; HERPES SIMPLEX VIRUS; HIGH RISK INFANT; HOSPITAL COST; HUMAN; INFANT MORTALITY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LABORATORY DIAGNOSIS; MORBIDITY; NERVOUS SYSTEM INJURY; NEWBORN INFECTION; PROGNOSIS; RISK ASSESSMENT; TREATMENT PLANNING; UNITED STATES; VACCINATION; VIRUS TRANSMISSION; ADULT; CESAREAN SECTION; DISEASE TRANSMISSION; FEMALE; HERPES SIMPLEX; LEGAL ASPECT; METHODOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PUBLIC HEALTH; VIROLOGY;

ADULT; CESAREAN SECTION; DISEASE NOTIFICATION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUBLIC HEALTH; UNITED STATES;

EID: 33645961309     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000187203.27918.45     Document Type: Article

References (36)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 1997; 337:1105-1111.
2. Langenberg AGM, Corey L, Ashley RL, et al. A prospective study of new infection with HSV-1 and HSV-2. N Engl J Med 1999; 341:1532-1538.
3. Prober C. Herpes simplex virus infections in pregnant women and neonates: an on-line continuing medical education publication of the American Herpes Foundation. 2003; 1:1-12.
4. Whitley RJ. Herpes simplex infection. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 3rd ed. Philadelphia: WB Saunders; 1990:282-305.
5. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17:1-13.
6. Leone P, Fleming DT, Gilsenan AW, et al. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis 2004; 31:311-316.
7. Szucs TD, Berger K, Fisman DN, Harbarth S. The estimated economic burden of genital herpes in the United States: an analysis using two cost approaches. BMC Infect Dis 2001; 1:5.
8. Chesson HW, Blandford JM, Gift TL, et al. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004; 36:11-19.
9. Rouse DJ, Stringer JSA. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000; 183:400-406.
10. Corey L, Handsfield HH. Genital herpes and public health addressing a global problem. JAMA 2000; 283:791-794.
11. Sullivan-Bolyai J, Hull HF, Wilson C, Corey L. Neonatal herpes simplex virus infection in King County, Washington: increasing incidence and epidemiologic correlates. JAMA 1983; 250:3059-3062.
12. Whitley RJ. Neonatal herpes simplex virus infections. J Med Virol 1993; 1(suppl):13-21.
13. Martin JA, Hamilton BE, Sutton PD, et al. Births: Final Data for 2002: National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics; 2003:52.
14. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289:203-209.
15. Riley LE. Herpes simplex virus. Semin Perinatol 1998; 22:284-292.
16. Hutto C, Arvin A, Jacobs R, et al. Intrauterine herpes simplex virus infection. J Pediatr 1987; 110:97-101.
17. Whitley RJ. Herpes simplex virus infections. In: Remington JS, Klein JO, eds. Infectious diseases of the Fetus and Newborn Infant. 3rd ed. Philadelphia: WB Saunders; 1990:282-305.
18. Brown ZA, Benedetti J, Ashely R, et al. Neonatal herpes simplex infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324:1247-1252.
19. Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes infection. N Engl J Med 1991; 324:444-449.
20. Whitley R, Nahmias A, Soong SJ, et al. Vidarabine therapy of neonatal herpes infections. Pediatrics 1980; 66:495-501.
21. Kimberlin DW, Chin-Yu L, Jocobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223-229.
22. Handsfield HH, Stone KM, Wasserheit JN. Prevention agenda for genital herpes. Sex Transm Dis 1999; 26:228-231.
23. Bauer H. NCSD HSV/HPV program survey results: NCSD national meeting, October 2003. Available at: http://www.ncsddc.org/meetings/2003/ NCSDViralSTDSurveyFinal.pdf. Accessed April 4, 2004.
24. Gutierrez KM, Halpern MSF, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 1999; 180:199-202.
25. Elliott E, Rose D. Reporting of communicable disease conditions under surveillance by the APSU, 1 January to 30 June 2003. Commun Dis Intell 2004; 28:4.
26. Marazzo JM, John GC, Krohn MA, Corey L. Cesarean delivery in women with genital herpes in Washington State, 1989-1991. Infect Dis Obstet Gynecol 1997; 5:29-35.
27. Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions: efficacy, risks, and costs. JAMA 1993; 270:77-82.
28. Garnett GP, Dubin G, Slaoui M, Darcis T. The potential epidemiological impact of a genital herpes vaccine for women. Sex Transm Infect 2004; 80:24-29.
29. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003; 102:1396-1403.
30. American College of Obstetricians and Gynecologists. ACOG practice bulletin: management of herpes in pregnancy. Int J Gynecol Obstet 2000; 68:165-174.
31. Ratanajamit C, Skriver MV, Jepsen P, et al. Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study. Scand J Infect Dis 2003; 35:255-259.
32. Scott LL, Alexander J. Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy. Am J Perinatol 1998; 15:57-62.
33. Scott LL, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87:69-73.
34. Corey L, Wald A, Patel R, et al. Valacyclovir HSV Transmission Study Group: once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
35. Crosby RA, DiClemente RJ, Wingood GM, Rose E. Testing for HSV-2 infection among pregnant teens: implications for clinical practice. J Pediatr Adolesc Gynecol 2003; 16:39-41.
36. Miyai T, Turner KR, Kent CK, Klausner J. The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2. Sex Transm Dis 2004; 31:517-521.